Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
Clinical trial NCT01372540 · COMPLETED
Trial details
- NCT number
- NCT01372540
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-24
- Primary completion
- 2019-05-16
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.